EF Hutton Reiterates Buy on Pasithea Therapeutics, Maintains $2 Price Target
BenzingaJul 11, 2023 00:15
EF Hutton Assumes Pasithea Therapeutics at Buy, Announces Price Target of $2
BenzingaJun 1, 2023 16:49
EF Hutton Adjusts Price Target on Pasithea Therapeutics to $2 From $2.30, Maintains Buy Rating
MT NewswiresApr 3, 2023 22:37
EF Hutton Maintains Buy on Pasithea Therapeutics, Lowers Price Target to $2
BenzingaApr 3, 2023 22:00
No Data
No Data